Antibody-Drug Conjugates Market: Comprehensive Analysis, Target Population, Competitive Dynamics, and 2034 Outlook
Antibody-drug conjugates are a revolutionary advancement in cancer treatment, combining monoclonal antibodies with powerful cytotoxic drugs to deliver highly targeted therapies. This innovative approach maximizes therapeutic efficacy while minimizing systemic toxicity, establishing antibody-drug conjugates as a key development in oncology. With the